Enhanced associations between subjective cognitive concerns and blood-based AD biomarkers using a novel EMA approach
EMA provides a more dynamic and potentially sensitive method for detecting early AD risk compared to traditional SCC assessments. These real-time measures could enhance early detection and clinical intervention, particularly in diverse and under-resourced populations. This study underscores the potential of EMA for broad applicability and inclusivity in monitoring AD progression and facilitating early therapeutic interventions.
Authors
- Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
- Jacqueline A. Mogle (ORCID: https://orcid.org/0000-0002-6082-228X)
- Cuiling Wang
- Nelson Roque (ORCID: https://orcid.org/0000-0003-1184-202X)
- Caroline O. Nester (ORCID: https://orcid.org/0000-0002-2494-2786)
- Carol A. Derby (ORCID: https://orcid.org/0000-0002-5657-4519)
- Laura A. Rabin (ORCID: https://orcid.org/0000-0002-8898-1514)
- Mindy Joy Katz (ORCID: https://orcid.org/0009-0004-7524-0292)
- Ángel García de la Garza
Institutions
- Albert Einstein College of Medicine (US)
- Pennsylvania State University (US)
- City University of New York (US)
- Brown University (US)
- Clemson University (US)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1186/s13195-025-01720-y
- Citations
- 3
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 4.41
Funders
- Carolyne E Czap and Eugene A Czap Charitable Foundation
- National Institutes of Health
- National Institute on Aging